Alex Dahmani

Alex Dahmani

Company: Adaptive Biotech

Job title: Director, Business Development


T Cell Biomarkers in Autoimmunity for Target Discovery & Treatment Monitoring 10:00 am

Use T-cell repertoire to determine HLA type for high-risk alleles Monitor-T cell response to immune modifying therapies as a biomarker of activity Map T-cell clones to self-antigens to identify disease targets and track antigenspecific response to therapyRead more

day: Day One

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.